Daniel Wolle

Stock Analyst at JP Morgan

(n/a)

# 4,407

Out of 4,761 analysts

3

Total ratings

n/a

Success rate

-39.16%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Daniel Wolle

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ITOS iTeos Therapeutics	Maintains: Overweight	$32 → $29	$7.41	+291.36%	2	Nov 13, 2023
	CARA Cara Therapeutics	Maintains: Overweight	$228 → $192	$4.97	+3,763.18%	1	Mar 7, 2023

iTeos Therapeutics

Nov 13, 2023

Maintains: Overweight

Price Target: $32 → $29

Current: $7.41

Upside: +291.36%

Cara Therapeutics

Mar 7, 2023

Maintains: Overweight

Price Target: $228 → $192

Current: $4.97

Upside: +3,763.18%